Zheng Xiaonan, Peng Ruilin, Xu Hang, Lin Tianhai, Qiu Shi, Wei Qiang, Yang Lu, Ai Jianzhong
Department of Urology and Institute of Urology of West China Hospital, Sichuan University, Chengdu, China.
Frontiers Science Center for Disease-Related Molecular Network, Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, China.
Front Nutr. 2022 Feb 25;9:783660. doi: 10.3389/fnut.2022.783660. eCollection 2022.
Controversial evidence about the association between cancer risk and metabolic status among individuals with obesity has been reported, but pooled data remain absent. This study aims to present pooled data comparing cancer risk between patients with metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO).
The current study systematically searched pieces of literature on January 4, 2021, of prospective cohorts that compare the incidence of cancer between MHO and MUO. The quality of included studies was assessed using Newcastle-Ottawa scale, and publication bias was evaluated using funnel plots.
Eleven high-quality studies were eventually selected. Quantitative analysis indicates that a lower cancer incidence exists for MHO phenotype than that for MUO (odds ratio [OR], 0.71; 95% confidential interval [CI], 0.61-0.84). Consistent outcomes are presented by subgroup analyses, which are grouped by cohort region (western population: [OR, 0.84; 95% CI, 0.75-0.93]; Asian population: [OR, 0.64; 95% CI, 0.54-0.77]); definition of metabolic unhealthiness (≥3 metabolic abnormalities: [OR, 0.62; 95% CI, 0.54-0.71]; ≥1 metabolic abnormality: [OR, 0.76; 95% CI, 0.62-0.94]); and definition of obesity (body mass index (BMI), ≥30 kg/m: [OR, 0.84; 95% CI, 0.73-0.98]; BMI, ≥25 kg/m: [OR, 0.53; 95% CI, 0.52-0.55]).
In conclusion, this study suggests a reduced cancer risk for MHO compared to MUO regardless of population heterogeneity, or the definitions of obesity and metabolic status.
关于肥胖个体癌症风险与代谢状态之间关联的证据存在争议,但仍缺乏汇总数据。本研究旨在提供汇总数据,比较代谢健康肥胖(MHO)患者和代谢不健康肥胖(MUO)患者的癌症风险。
本研究于2021年1月4日系统检索了比较MHO和MUO癌症发病率的前瞻性队列研究文献。采用纽卡斯尔-渥太华量表评估纳入研究的质量,并使用漏斗图评估发表偏倚。
最终选取了11项高质量研究。定量分析表明,MHO表型的癌症发病率低于MUO(优势比[OR],0.71;95%置信区间[CI],0.61 - 0.84)。亚组分析呈现出一致的结果,亚组按队列地区分组(西方人群:[OR,0.84;95% CI,0.75 - 0.93];亚洲人群:[OR,0.64;95% CI,0.54 - 0.77])、代谢不健康的定义(≥3种代谢异常:[OR,